# A Food Effect Study of TAK-385 Final Formulation

> **NCT02792062** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 12 (actual)

## Conditions studied

- Japanese Premenopausal Healthy Adult Women

## Interventions

- **DRUG:** TAK-385 40 mg

## Key facts

- **NCT ID:** NCT02792062
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-04
- **Primary completion:** 2016-08-31
- **Final completion:** 2016-08-31
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02792062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02792062, "A Food Effect Study of TAK-385 Final Formulation". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02792062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*